Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.

The cost-effectiveness agency for England and Wales says it can’t recommend routine NHS use of Aimovig (erenumab) for people suffering at least four migraine episodes each month, even though it ...

In the US study, 30 adults with severe rosacea were given the migraine drug erenumab. The jab blocks the effect of a protein which is linked to the debilitating headaches and nausea of migraine.

Aimovig’s (erenumab-aooe) dosage for migraine prevention is typically one 70-milligram (mg) injection per month. Your doctor might increase your dosage to 140 mg per month, depending on your ...

Novartis and Amgen already filed their migraine drug Aimovig (erenumab) with the FDA in late July, the first from the calcitonin gene-related peptide (CGRP) inhibitor class to get a review.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.